Immucor Board of Directors Re-Elected

	Immucor, Inc. (NASDAQ: BLUD) is a leading supplier of diagnostic reagents and automated instrumentation to ensure the safety of blood transfusions
	Kairos Partners, an 11.6% Immucor shareholder, launched a proxy contest to replace Immucor's board of directors with an alternative slate of directors
	TM Capital Corp. served as advisor to Immucor in its successful effort to defeat the dissident slate and re-elect Immucor's existing directors